|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02274363 |
|
Date of registration:
|
22/10/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis
|
|
Scientific title:
|
Assessment of Psoriasis Severity in Brazilians Patients With Chronic Plaque-type Psoriasis Attending Outpatient Clinics: a Multicenter, Observational, and Cross-sectional Study (APPISOT) |
|
Date of first enrolment:
|
April 10, 2012 |
|
Target sample size:
|
1131 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02274363 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
Janssen Pharmaceutica Clinical Trial |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Janssen Pharmaceutica |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Participant diagnosed with chronic plaque psoriasis
- Participant is at least 18 years old
- Participant is able to understand and sign the Informed Consent Form
Exclusion Criteria:
- In the opinion of the investigator, the participant is unable or unavailable to
complete all study procedures
- Participant suffers from a psychiatric condition or any other clinical condition that
might interfere with the ability to understand the study requirements
- Participant refuses consent or is unwilling to supply the required information within
the required period
- Participant is taking part in an interventionist clinical trial with an
investigational agent (i.e. non-commercialized agent) or in an interventionist
clinical trial sponsored by Johnson & Johnson
- Participant is an employee of the investigator or study site and is directly involved
in the conduction of this study or other studies conducted by the same investigator at
the same site, or is a family member of the employee or investigator
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Plaque
|
|
Psoriasis
|
|
Intervention(s)
|
|
Other: No Intervention
|
|
Primary Outcome(s)
|
|
Participant's Psoriasis Severity
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Secondary Outcome(s)
|
|
Number of Participants With Alcohol Abuse
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Participant Current Psoriasis Severity
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Health Related Quality of Life (HRQoL) Score
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Disease Duration
[Time Frame: Time from disease diagnosis to inclusion (up to 12 months)]
|
|
Brief Pain Inventory (BPI) Scale Score
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Hospital Anxiety and Depression Scale (HADS) Score
[Time Frame: At single study visit anytime between 6 to 12 months]
|
|
Number of Participants With Comorbidities
[Time Frame: At single stuy visit anytime between 6 to 12 months]
|
|
Secondary ID(s)
|
|
CR100727
|
|
CNTO1275PSY0001
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|